WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Operating Cash Flow
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Operating Cash Flow of $15.25 million for the 9-month period ending 2012-09-30, per its 10-Q/A filed 2012-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-12-11
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was $4.22M, a 19.14% increase year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was $1.28M.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was $9.74M, a 7.90% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was $18.52M, a 3.69% increase year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. net cash provided by (used in) operating activities for fiscal 2011 was $30.45M, a 10.94% decline from fiscal 2010.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. net cash provided by (used in) operating activities for fiscal 2010 was $34.19M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-09-30 | $4.22M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11 | $5.50M derived: sum of 2 quarters · filed 2012-12-11 | $15.25M 10-Q/A · filed 2012-12-11 | $33.77M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-06-30 | $1.28M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30 | $11.02M 10-Q/A · filed 2012-08-30 | $29.55M derived: sum of 3 quarters · filed 2012-08-30 | $33.09M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-03-31 | $9.74M 10-Q · filed 2012-05-15 | $28.27M derived: sum of 2 quarters · filed 2012-05-15 | $31.81M derived: sum of 3 quarters · filed 2012-12-11 | $29.62M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-12-31 | $18.52M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $22.07M derived: sum of 2 quarters · filed 2012-12-11 | $19.87M derived: sum of 3 quarters · filed 2012-12-11 | $30.45M 10-K · filed 2012-03-30 |
| 2011-09-30 | $3.54M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11 | $1.35M derived: sum of 2 quarters · filed 2012-12-11 | $11.93M 10-Q/A · filed 2012-12-11 | $29.79M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-06-30 | -$2.20M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30 | $8.38M 10-Q/A · filed 2012-08-30 | $26.25M derived: sum of 3 quarters · filed 2012-08-30 | $35.34M derived: sum of 4 quarters · filed 2012-08-30 |
| 2011-03-31 | $10.58M 10-Q · filed 2012-05-15 | $28.45M derived: sum of 2 quarters · filed 2012-05-15 | $37.54M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $17.87M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $26.96M derived: sum of 2 quarters · filed 2012-03-30 | $34.19M 10-K · filed 2012-03-30 | |
| 2010-09-30 | $9.09M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $16.33M 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $7.23M 10-Q/A · filed 2011-09-01 |